Gemini Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
1.50
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.09
|
-0.08
|
0.01
|
11.11%
|
|
2022-06-30
|
-2.00
|
-1.60
|
0.40
|
20.00%
|
|
2022-03-31
|
-3.01
|
-3.50
|
-0.49
|
-16.28%
|
|
2021-12-31
|
-4.97
|
-4.10
|
0.87
|
17.51%
|
|
2021-09-30
|
-4.73
|
-4.30
|
0.43
|
9.09%
|
|
2021-06-30
|
-4.00
|
-3.80
|
0.20
|
5.00%
|
|
2021-03-31
|
-3.65
|
-5.90
|
-2.25
|
-61.64%
|
|
2020-12-31
|
-11.80
|
-2.03
|
9.77
|
82.80%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-5.18
|
|
2021-12-31
|
-18.10
|
|
2020-12-31
|
-5.37
|
|
2019-12-31
|
-7.46
|
|
2018-12-31
|
-2.06
|